| Title |
Author(s) |
Journal |
Issue Date |
Type |
|
Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance
|
Wright, A.; Zignol, M.; Van Deun, A.; Falzon, D.; Ruesch Gerdes, S.; Feldman, K.; Hoffner, S.; Drobniewski, F.; Barrera, L.; van Soolingen, D.; Boulabhal, F.; Paramasivan, C. N.; Kam, K. M.; Mitarai, S.; Nunn, P.; Raviglione, M.
|
Lancet |
2009
|
Article
|
|
Bulk acid-fast staining of sputum smears: time to end a taboo
|
Kam, K. M.; Yip, C. W.; Tang, H. S.; Van Deun, A.
|
International Journal of Tuberculosis and Lung Disease |
2009
|
Article
|
|
Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results
|
Van Deun, A.; Barrera, L.; Bastian, I.; Fattorini, L.; Hoffmann, H.; Kam, K. M.; Rigouts, L.; Rüsch-Gerdes, S.; Wright, A.
|
Journal of Clinical Microbiology |
2009
|
Article
|
|
Is second-line anti-tuberculosis drug susceptibility testing reliable? [letter]
|
Kim, S. J.; Espinal, M. A.; Abe, C.; Bai, G. H.; Boulahbal, F.; Fattorini, L.; Gilpin, C.; Hoffner, S.; Kam, K. M.; Martin-Casabona, N.; Rigouts, L.; Vincent, V.
|
International Journal of Tuberculosis and Lung Disease |
2004
|
Letter
|